Ruth Coll. Bsc Dis

Ruth Coll holds a Bachelor of Science with Honours and a Master of Business Administration. Currently serving as a Senior Clinical Study Director at SynOx Therapeutics since March 2024, Ruth has extensive experience in clinical operations and program management. Previous roles include Director at Genomics plc, Senior Clinical Program Manager/Director at Trizell Ltd, and Director of Clinical Operations at Daiichi Sankyo UK Ltd. Additionally, Ruth has held director positions at Shire Pharmaceuticals and served as a Senior Clinical Scientist at Shire and a Clinical Research Associate at Eli Lilly UK. Ruth's educational background includes a Master of Business Administration from the University of Bradford and studies at Ulster University.